SPUTNIK V VACCINE RECEIVES APPROVAL FOR PRODUCTION IN TURKEY

Details have been released about the production of the Russian Sputnik V vaccine in Turkey, developed against COVID-19. VisCoran Ilac Sanayii AS has signed a deal with the Russian Direct Investment Fund (RDIF) on the vaccine’s manufacturing rights and is in negotiation with four Turkish companies Polfarma, Mefar, Onko and Arven – which have received Good Manufacturing Practice (GMP) approval, according to Ozturk Oran, Board Chairman of VisCoran Ilac Sanayii AS. After 9 months of negotiations with the Russians, VisCoran Ilac Sanayii AS plans to approach these four companies if they obtain a highcapacity manufacturing “We agreed with them in principle. We are discussing the details now,” Oran said.